Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.
1991; Lippincott Williams & Wilkins; Volume: 17; Issue: 5 Linguagem: Inglês
10.1161/01.hyp.17.5.720
ISSN1524-4563
AutoresF. Merlin Bumpus, Kevin Catt, Andrew T. Chiu, Marc deGasparo, Theodore L. Goodfriend, Ahsan Husain, M J Peach, David G. Taylor, P B Timmermans,
Tópico(s)Health Sciences Research and Education
ResumoHomeHypertensionVol. 17, No. 5Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBNomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. F M Bumpus, K J Catt, A T Chiu, M DeGasparo, T Goodfriend, A Husain, M J Peach, D G TaylorJr and P B Timmermans F M BumpusF M Bumpus Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , K J CattK J Catt Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , A T ChiuA T Chiu Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , M DeGasparoM DeGasparo Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , T GoodfriendT Goodfriend Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , A HusainA Husain Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , M J PeachM J Peach Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. , D G TaylorJrD G TaylorJr Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. and P B TimmermansP B Timmermans Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195. Originally published1 May 1991https://doi.org/10.1161/01.HYP.17.5.720Hypertension. 1991;17:720–721"Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.." Hypertension, 17(5), pp. 720–721 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByFerrario C, Iyer S, Burnett J, Ahmad S, Wright K, VonCannon J, Saha A and Groban L (2021) Angiotensin (1–12) in Humans With Normal Blood Pressure and Primary Hypertension, Hypertension, 77:3, (882-890), Online publication date: 3-Mar-2021. Biswal S, Ghosh R and Acharya P (2020) Pharmacology of Angiotensin and Its Receptors Frontiers in Pharmacology of Neurotransmitters, 10.1007/978-981-15-3556-7_11, (361-380), . Sharma M and Kohli D (2020) STRUCTURAL REQUIREMENTS OF SOME TRIAZOLONE DERIVATIVES USING TOPOLOGICAL AND PHYSICOCHEMICAL DESCRIPTORS: QSAR APPROACH, INDIAN DRUGS, 10.53879/id.57.04.11853, 57:04, (15-19), Online publication date: 1-Jul-2020. Eguchi S, Kawai T, Scalia R and Rizzo V (2018) Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology, Hypertension, 71:5, (804-810), Online publication date: 1-May-2018. Forrester S, Booz G, Sigmund C, Coffman T, Kawai T, Rizzo V, Scalia R and Eguchi S (2018) Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology, Physiological Reviews, 10.1152/physrev.00038.2017, 98:3, (1627-1738), Online publication date: 1-Jul-2018. Sharma M and Kohli D (2017) DEVELOPMENT OF A ROBUST QSAR MODEL OF ANGIOTENSIN RECEPTOR REVEALS A K NEAREST NEIGHBOR APPLICABLE TO DIVERSE SCAFFOLDS, INDIAN DRUGS, 10.53879/id.54.06.10947, 54:06, (30-36), Online publication date: 28-Jun-2017. Smajić M, Nikolić K, Vujić Z, Ahmetović L and Kuntić V (2015) 3D-QSAR studies and pharmacophore identification of AT1 receptor antagonists, Medicinal Chemistry Research, 10.1007/s00044-015-1470-1, 25:1, (51-61), Online publication date: 1-Jan-2016. Paz M, Marchese N, Bregonzio C and Baiardi G (2015) Brain Renin-Angiotensin System: A Novel Therapeutic Target for Psychostimulant and Alcohol Related Disorders? Psychiatry and Neuroscience Update, 10.1007/978-3-319-17103-6_7, (79-88), . de Gasparo M, Whitebread S, Criscione L, Buehlmayer P and Furet P (2015) The AT2 Receptor The Protective Arm of the Renin Angiotensin System (RAS), 10.1016/B978-0-12-801364-9.00002-X, (11-16), . TAKAHASHI S, YOSHIYA T, YOSHIZAWA-KUMAGAYE K and SUGIYAMA T (2015) Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean , Biomedical Research, 10.2220/biomedres.36.219, 36:3, (219-224), . Karnik S, Unal H, Kemp J, Tirupula K, Eguchi S, Vanderheyden P, Thomas W and Ohlstein E (2015) International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli, Pharmacological Reviews, 10.1124/pr.114.010454, 67:4, (754-819), Online publication date: 1-Oct-2015. Hong S, Bidur B, Choi M, Seo Y and Lim D (2013) Influence of PD 123319 (AT 2 -Receptor Antagonist) on Catecholamine Secretion in the Perfused Rat Adrenal Medulla , Journal of the Korean Society of Hypertension, 10.5646/jksh.2013.19.1.23, 19:1, (23), . Patel B and Mehta A (2012) Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases, European Journal of Pharmacology, 10.1016/j.ejphar.2012.09.034, 697:1-3, (1-12), Online publication date: 1-Dec-2012. Li Y and Anand-Srivastava M (2012) Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells, Canadian Journal of Physiology and Pharmacology, 10.1139/y2012-042, 90:8, (1105-1116), Online publication date: 1-Aug-2012. Chang L, Yang R, Wang M, Liu J, Wang Y, Zhang H and Li Y (2012) Angiotensin II Type-1 Receptor-JAK/STAT Pathway Mediates the Induction of Visfatin in Angiotensin II-Induced Cardiomyocyte Hypertrophy, The American Journal of the Medical Sciences, 10.1097/MAJ.0b013e31822993ff, 343:3, (220-226), Online publication date: 1-Mar-2012. Yanagisawa H, Koike H and Miura S (2012) Olmesartan Medoxomil: An Angiotensin II Receptor Blocker Case Studies in Modern Drug Discovery and Development, 10.1002/9781118219683.ch3, (45-66) Marc Y and Llorens-Cortes C (2011) The role of the brain renin–angiotensin system in hypertension: Implications for new treatment, Progress in Neurobiology, 10.1016/j.pneurobio.2011.06.006, 95:2, (89-103), Online publication date: 1-Oct-2011. Ferrario C (2009) New Physiological Concepts of the Renin-Angiotensin System From the Investigation of Precursors and Products of Angiotensin I Metabolism, Hypertension, 55:2, (445-452), Online publication date: 1-Feb-2010.Ren Y, D'Ambrosio M, Garvin J and Carretero O (2010) Angiotensin II Enhances Connecting Tubule Glomerular Feedback, Hypertension, 56:4, (636-642), Online publication date: 1-Oct-2010. Bhuiyan M and Nagatomo T (2010) Assessment of Homologous Internalization of Constitutively Active N111G Mutant of AT1 Receptor Constitutive Activity in Receptors and Other Proteins, Part A, 10.1016/B978-0-12-381298-8.00009-5, (165-177), . Bhuiyan M, Hossain M, Nakamura T, Ozaki M and Nagatomo T (2010) Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan, Journal of Pharmacological Sciences, 10.1254/jphs.09343SC, 112:4, (459-462), . Bhuiyan M, Hossain M, Ishiguro M, Nakamura T and Nagatomo T (2010) Engineered Mutation of Some Important Amino Acids in Angiotensin II Type 1 (AT1) Receptor Increases the Binding Affinity of AT1-Receptor Antagonists, Journal of Pharmacological Sciences, 10.1254/jphs.09361FP, 113:1, (57-65), . Bhuiyan M, Ishiguro M, Hossain M, Nakamura T, Ozaki M, Miura S and Nagatomo T (2009) Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling, Life Sciences, 10.1016/j.lfs.2009.05.001, 85:3-4, (136-140), Online publication date: 1-Jul-2009. Daniels D and Fluharty S (2009) Neuroendocrinology of Body Fluid Homeostasis Hormones, Brain and Behavior, 10.1016/B978-008088783-8.00007-3, (259-289), . Bhuiyan M, Hossain M, Miura S, Nakamura T, Ozaki M and Nagatomo T (2009) Constitutively Active Mutant N111G of Angiotensin II Type 1 (AT1) Receptor Induces Homologous Internalization Through Mediation of AT1-Receptor Antagonist, Journal of Pharmacological Sciences, 10.1254/jphs.09202FP, 111:3, (227-234), . Barra S, Vitagliano A, Cuomo V, Vitagliano G and Gaeta G (2009) Vascular and metabolic effects of angiotensin II receptor blockers, Expert Opinion on Pharmacotherapy, 10.1517/14656560802653180, 10:2, (173-189), Online publication date: 1-Feb-2009. Messadi-Laribi E, Griol-Charhbili V, Gaies E, Vincent M, Heudes D, Meneton P, Alhenc-Gelas F and Richer C (2008) CARDIOPROTECTION AND KALLIKREIN–KININ SYSTEM IN ACUTE MYOCARDIAL ISCHAEMIA IN MICE, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.2008.04902.x, 35:4, (489-493), Online publication date: 1-Apr-2008. Navar L, Arendshorst W, Pallone T, Inscho E, Imig J and Bell P (2008) The Renal Microcirculation Microcirculation, 10.1016/B978-0-12-374530-9.00015-2, (550-683), . Navar L, Arendshorst W, Pallone T, Inscho E, Imig J and Bell P (2008) The Renal Microcirculation Comprehensive Physiology, 10.1002/cphy.cp020413, (550-683), Online publication date: 1-Dec-2008. Mehta P and Griendling K (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00287.2006, 292:1, (C82-C97), Online publication date: 1-Jan-2007. Goette A, Lendeckel U and Klein H Elektrophysiologie und Pathophysiologie von Vorhofflimmern Vorhofflimmern Vorhofflattern, 10.1007/978-3-7985-1748-6_4, (39-73) Messadi-Laribi E, Griol-Charhbili V, Pizard A, Vincent M, Heudes D, Meneton P, Alhenc-Gelas F and Richer C (2007) Tissue Kallikrein Is Involved in the Cardioprotective Effect of AT1-Receptor Blockade in Acute Myocardial Ischemia, Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.107.124859, 323:1, (210-216), Online publication date: 1-Oct-2007. Gallagher P, Tallant E and Ferrario C Angiotensin Converting Enzyme 2: A Critical Regulator of the Renin-Angiotensin System The Local Cardiac Renin Angiotensin-Aldosterone System, 10.1007/0-387-27826-5_11, (129-142) Gallagher P, Chappell M, Ferrario C and Tallant E (2006) Distinct roles for ANG II and ANG-(1–7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes, American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00409.2004, 290:2, (C420-C426), Online publication date: 1-Feb-2006. Wang L, Flannery P, Athirakul K, Dunn S, Kourany W and Spurney R (2006) Gαq-dependent signaling cascades stimulate water-seeking behavior, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00401.2005, 291:4, (F781-F789), Online publication date: 1-Oct-2006. Fukada S, Tirapelli C, de Godoy M and de Oliveira A (2005) Mechanisms Underlying the Endothelium-Independent Relaxation Induced by Angiotensin II in Rat Aorta, Journal of Cardiovascular Pharmacology, 10.1097/01.fjc.0000151929.34896.c3, 45:2, (136-143), Online publication date: 1-Feb-2005. Wilms H, Rosenstiel P, Unger T, Deuschl G and Lucius R (2005) Neuroprotection with Angiotensin Receptor Antagonists, American Journal of Cardiovascular Drugs, 10.2165/00129784-200505040-00004, 5:4, (245-253), . Shi L, Mao C, Thornton S, Sun W, Wu J, Yao J and Xu Z (2005) Effects of intracerebroventricular losartan on angiotensin II-mediated pressor responses andc-fos expression in near-term ovine fetus, The Journal of Comparative Neurology, 10.1002/cne.20802, 493:4, (571-579), Online publication date: 26-Dec-2005. Langeveld B, Roks A, Tio R, Voors A, Zijlstra F and van Gilst W (2005) Renin-Angiotensin System Intervention to Prevent In-Stent Restenosis, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200501000-00015, 45:1, (88-98), Online publication date: 1-Jan-2005. Banday A, Siddiqui A, Menezes M and Hussain T (2005) Insulin treatment enhances AT 1 receptor function in OK cells , American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00361.2003, 288:6, (F1213-F1219), Online publication date: 1-Jun-2005. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T and Kurabayashi M (2005) Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction, Journal of the American College of Cardiology, 10.1016/j.jacc.2004.11.038, 45:5, (661-667), Online publication date: 1-Mar-2005. Ferrario C, Trask A and Jessup J (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00618.2005, 289:6, (H2281-H2290), Online publication date: 1-Dec-2005. Diz D, Chappell M, Tallant E and Ferrario C (2005) Angiotensin-(1-7) Hypertension, 10.1016/B978-0-7216-0258-5.50100-9, (100-110), . Tchekalarova J and Georgiev V (2005) Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?, Life Sciences, 10.1016/j.lfs.2004.10.012, 76:9, (955-970), Online publication date: 1-Jan-2005. Ferrario C, Averill D, Brosnihan K, Chappell M, Diz D, Gallagher P and Tallant E (2004) Angiotensin-(1–7). Its Contribution to Arterial Pressure Control Mechanisms Angiotensin Vol. I, 10.1007/978-3-642-18495-6_21, (477-518), . Allgeier J and Hauf G (2004) Pharmakotherapie des Renin-Angiotensin- Aldosteron-Systems Herzkrankheiten, 10.1007/978-3-642-18649-3_47, (943-959), . Pan H (2016) Brain Angiotensin II and Synaptic Transmission, The Neuroscientist, 10.1177/1073858404264678, 10:5, (422-431), Online publication date: 1-Oct-2004. Yang L, Zhang G, Zou N and Qi C (2003) Facile synthesis of novel nonpeptide angiotensin II receptor antagonists, Journal of Heterocyclic Chemistry, 10.1002/jhet.5570400623, 40:6, (1107-1112), Online publication date: 1-Nov-2003. Wang L, Flannery P and Spurney R (2003) Characterization of angiotensin II–receptor subtypes in podocytes, Journal of Laboratory and Clinical Medicine, 10.1016/S0022-2143(03)00139-2, 142:5, (313-321), Online publication date: 1-Nov-2003. Becker M, Umrani D, Lokhandwala M and Hussain T (2003) Increased Renal Angiotensin II AT 1 Receptor Function in Obese Zucker Rat , Clinical and Experimental Hypertension, 10.1081/CEH-120017739, 25:1, (35-47), Online publication date: 1-Jan-2003. Bagi É, Fekete É and Lénárd L (2003) Angiotensin II and III microinjections into the zona incerta influence drinking behavior, Brain Research, 10.1016/S0006-8993(03)02680-5, 977:2, (199-208), Online publication date: 1-Jul-2003. Schuijt M, Saxena P and Danser A (2002) No Net Effect of Angiotensin II on Blood Pressure?, Hypertension, 39:5, (e27-e28), Online publication date: 1-May-2002.Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, de Gasparo M and Horiuchi M (2002) Effect of Angiotensin II Type 1 Receptor Blockade on Cardiac Remodeling in Angiotensin II Type 2 Receptor Null Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, 22:1, (49-54), Online publication date: 1-Jan-2002. de Gasparo M (2002) Les r??cepteurs AT1 et AT2 de l??angiotensine II, Drugs, 10.2165/00003495-200262991-00001, 62:Special Issue 1, (1-10), . de Godoy M and de Oliveira A (2002) Cross-Talk Between AT 1 and AT 2 Angiotensin Receptors in Rat Anococcygeus Smooth Muscle , Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.102.036970, 303:1, (333-339), Online publication date: 1-Oct-2002. Rosenstiel P, Gallinat S, Arlt A, Unger T, Sievers J and Lucius R (2002) Angiotensin AT2 Receptor Ligands, CNS Drugs, 10.2165/00023210-200216030-00001, 16:3, (145-153), . Fluharty S (2002) Neuroendocrinology of Body Fluid Homeostasis Hormones, Brain and Behavior, 10.1016/B978-012532104-4/50010-X, (525-569), . Fierens F, Vanderheyden P, Roggeman C, Vande Gucht P, De Backer J and Vauquelin G (2002) Distinct binding properties of the AT1 receptor antagonist [3H]candesartan to intact cells and membrane preparations, Biochemical Pharmacology, 10.1016/S0006-2952(02)00859-6, 63:7, (1273-1279), Online publication date: 1-Apr-2002. KIMURA M, MITANI H and ISOMURA Y (2002) Preclinical and clinical profile of valsartan, a selective angiotensin II type-1 receptor blocker., Folia Pharmacologica Japonica, 10.1254/fpj.120.353, 120:5, (353-360), . Tokunaga R, Kushiku K, Yamada K, Yamada H and Furukawa T (2001) Possible Involvement of Calcium-Calmodulin Pathways in the Positive Chronotropic Response to Angiotensin II on the Canine Cardiac Sympathetic Ganglia, Japanese Journal of Pharmacology, 10.1254/jjp.86.381, 86:4, (381-389), . Frolkis I, Gurevitch J, Yuhas Y, Iaina A, Wollman Y, Chernichovski T, Paz Y, Matsa M, Pevni D, Kramer A, Shapira I and Mohr R (2001) Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)01055-X, 37:1, (316-322), Online publication date: 1-Jan-2001. Wang H, Garvin J and Carretero O (2001) Angiotensin II enhances tubuloglomerular feedback via luminal AT1 receptors on the macula densa, Kidney International, 10.1046/j.1523-1755.2001.00999.x, 60:5, (1851-1857), Online publication date: 1-Nov-2001. Okereke C and Messerli F (2007) Efficacy and Safety of Angiotensin II Receptor Blockers in Elderly Patients With Mild to Moderate Hypertension, The American Journal of Geriatric Cardiology, 10.1111/j.1076-7460.2001.90855.x, 10:1, (42-49), Online publication date: 1-Jan-2001. Vauquelin G, Fierens F, Verheijen I and Vanderheyden P (2016) Distinctions between non-peptide angiotensin II AT1-receptor antagonists, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/14703203010020010401, 2:1_suppl, (S24-S31), Online publication date: 1-Mar-2001. Sánchez-Mendoza A, López-Sánchez P, Vázquez-Cruz B, Rios A, Martínez-Ayala S and Escalante B (2000) Angiotensin II Modulates Ion Transport in Rat Proximal Tubules through CYP Metabolites, Biochemical and Biophysical Research Communications, 10.1006/bbrc.2000.2807, 272:2, (423-430), Online publication date: 1-Jun-2000. Liu M, Floten H, Furnary A, Yim A and He G (2000) Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts, The Annals of Thoracic Surgery, 10.1016/S0003-4975(00)01935-4, 70:6, (2064-2069), Online publication date: 1-Dec-2000. MYOU S, FUJIMURA M, KURASHIMA K, TACHIBANA H, WATANABE K and HIROSE T (2000) Type 1 Angiotensin II Receptor Antagonism Reduces Antigen-induced Airway Reactions, American Journal of Respiratory and Critical Care Medicine, 10.1164/ajrccm.162.1.9907128, 162:1, (45-49), Online publication date: 1-Jul-2000. Reagan L (2000) The Central Renin-Angiotensin System in Cardiovascular Regulation The Nervous System and the Heart, 10.1007/978-1-59259-713-0_11, (415-465), . Robertson M (2008) Angiotensin Antagonists, Journal of Receptors and Signal Transduction, 10.3109/10799890009150645, 20:4, (211-234), Online publication date: 1-Jan-2000. Mondorf U, Geiger H, Herrero M, Zeuzem S and Piiper A (2000) Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells, FEBS Letters, 10.1016/S0014-5793(00)01433-2, 472:1, (129-132), Online publication date: 21-Apr-2000. Kumar S, Maurya D and Chandra M (2016) ACE Inhibition versus Angiotensin-II Antagonism in Heart Failure, Asian Cardiovascular and Thoracic Annals, 10.1177/021849230000800229, 8:2, (195-203), Online publication date: 1-Jun-2000. Freeman M, Kanyicska B, Lerant A and Nagy G (2000) Prolactin: Structure, Function, and Regulation of Secretion, Physiological Reviews, 10.1152/physrev.2000.80.4.1523, 80:4, (1523-1631), Online publication date: 10-Jan-2000. Harrison-Bernard L, El-Dahr S, O'Leary D and Navar L (1999) Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension, Hypertension, 33:1, (340-346), Online publication date: 1-Jan-1999.Tallant E, Diz D and Ferrario C (1999) Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle, Hypertension, 34:4, (950-957), Online publication date: 1-Oct-1999. Gallinat S, Edling O and Unger T (1999) Das Renin-Angiotensin-System: Physiologie und Pathophysiologie Angiotensin II AT1-Rezeptorantagonisten, 10.1007/978-3-642-93705-7_1, (1-38), . Alova L, Stancheva S, Matsoukas J and Georgiev V (1999) Effects of peptide and non-peptide antagonists of angiotensin II receptors on drinking behavior in rats, Journal of Physiology-Paris, 10.1016/S0928-4257(99)80154-5, 93:3, (219-224), Online publication date: 1-May-1999. Lanctôt P, Leclerc P, Escher E, Leduc R and Guillemette G (1999) Role of N-Glycosylation in the Expression and Functional Properties of Human AT 1 Receptor , Biochemistry, 10.1021/bi9830516, 38:27, (8621-8627), Online publication date: 1-Jul-1999. Cobb C, Williamson R and Brown J (1999) Angiotensin II-Induced Calcium Signalling in Isolated Glomeruli from Fish Kidney (Oncorhynchus mykiss) and Effects of Losartan, General and Comparative Endocrinology, 10.1006/gcen.1998.7209, 113:2, (312-321), Online publication date: 1-Feb-1999. Muscella A, Marsigliante S, Vilella S, Jimenez E and Storelli C (1999) Angiotensin II stimulates the exchanger in human umbilical vein endothelial cells via AT1 receptor, Life Sciences, 10.1016/S0024-3205(99)00505-6, 65:22, (2385-2394), Online publication date: 1-Oct-1999. Fierens F, Vanderheyden P, De Backer J and Vauquelin G (1999) Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells, European Journal of Pharmacology, 10.1016/S0014-2999(98)00965-0, 367:2-3, (413-422), Online publication date: 1-Feb-1999. Humke and Uder (2001) Renovascular hypertension: the diagnosis and management of renal ischaemia, BJU International, 10.1046/j.1464-410x.1999.00306.x, 84:5, (555-569) Sander G, McKinnie J, Greenberg S and Giles T (1999) Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction, Progress in Cardiovascular Diseases, 10.1053/pcad.1999.0410265, 41:4, (265-300), Online publication date: 1-Feb-1999. Laporte S, Boucard A, Servant G, Guillemette G, Leduc R and Escher E (1999) Determination of Peptide Contact Points in the Human Angiotensin II Type I Receptor (AT1) with Photosensitive Analogs of Angiotensin II, Molecular Endocrinology, 10.1210/mend.13.4.0270, 13:4, (578-586), Online publication date: 1-Apr-1999. Martineau D, Lamouche S, Briand R and Yamaguchi N (1999) Functional involvement of angiotensin AT 2 receptor in adrenal catecholamine secretion in vivo , Canadian Journal of Physiology and Pharmacology, 10.1139/y99-037, 77:5, (367-374), Online publication date: 15-Jun-1999. Palaparti A, Ge C and Anand-Srivastava M (1999) Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity, Archives of Biochemistry and Biophysics, 10.1006/abbi.1999.1153, 365:1, (113-122), Online publication date: 1-May-1999. Stroth U and Unger T (1999) The Renin-Angiotensin System and Its Receptors, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199900001-00005, 33, (S21-S28), . Keifu S, Hironori K, Shinji T, Naotaka S, Takeo W, Yoshiyuki I and Mizuo M (1999) Inhibition of the Angiotensin II Type 1 Receptor by TCV-116: Quantitation by In Vitro Autoradiography, Japanese Journal of Pharmacology, 10.1254/jjp.79.131, 79:2, (131-139), . Rangel L, Caruso-Neves C, Lara L, Brasil F and Lopes A (1999) Angiotensin II activates the ouabain-insensitive Na+-ATPase from renal proximal tubules through a G-protein, Biochimica et Biophysica Acta (BBA) - Biomembranes, 10.1016/S0005-2736(98)00234-X, 1416:1-2, (309-319), Online publication date: 1-Jan-1999. Heerding J, Yee D, Krichavsky M and Fluharty S (1998) Mutational analysis of the angiotensin type 2 receptor: contribution of conserved amino acids in the region of the sixth transmembrane domain, Regulatory Peptides, 10.1016/S0167-0115(98)00030-5, 74:2-3, (113-119), Online publication date: 1-Jun-1998. Sakai R, Ma L and Fluharty S (1998) Antisense Approaches to Investigate the Neuroendocrine Control of Thirst and Sodium Appetite in The Rat Modulating Gene Expression by Antisense Oligonucleotides to Understand Neural Functioning, 10.1007/978-1-4615-4933-8_8, (125-140), . Bouley R, Pérodin J, Plante H, Řihakova L, Bernier S, Maletı́nská L, Guillemette G and Escher E (1998) N- and C-terminal structure–activity study of angiotensin II on the angiotensin AT2 receptor, European Journal of Pharmacology, 10.1016/S0014-2999(97)01549-5, 343:2-3, (323-331), Online publication date: 1-Feb-1998. Zorba Paster R, Snavely D, Sweet A, Draper R, Goldberg A, Soffer B and Sweet C (1998) Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors, Clinical Therapeutics, 10.1016/S0149-2918(98)80079-9, 20:5, (978-989), Online publication date: 1-Sep-1998. Anand-Srivastava M and Palaparti A (1998) Angiotensin II Enhanced The Expression Of Inhibitory Guanine Nucleotide Regulatory Protein in Vascular Smooth Muscle Cells: Blockade By at1 Antagonist Angiotensin II Receptor Blockade Physiological and Clinical Implications, 10.1007/978-1-4615-5743-2_5, (51-64), . Gimonet V, Bussieres L, Medjebeur A, Gasser B, Lelongt B and Laborde K (1998) Nephrogenesis and angiotensin II receptor subtypes gene expression in the fetal lamb, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.1998.274.6.F1062, 274:6, (F1062-F1069), Online publication date: 1-Jun-1998. Paz Y, Gurevitch J, Frolkis I, Matsa M, Kramer A, Locker C, Mohr R and Keren G (1998) Effects of an Angiotensin II Antagonist on Ischemic and Nonischemic Isolated Rat Hearts, The Annals of Thoracic Surgery, 10.1016/S0003-4975(97)01234-4, 65:2, (474-479), Online publication date: 1-Feb-1998. Dostal D, Hunt R, Kule C and Baker K (1998) Developmental Regulatlon of the Cardiac Renin-Angiotensin System: Expression and Associatlon With Growth and Apoptosis Angiotensin II Receptor Blockade Physiological and Clinical Implications, 10.1007/978-1-4615-5743-2_30, (403-414), . Pfaffendorf M (2016) Angiotensin-Converting Enzyme Inhibitors an Angiotensin II-Receptor Antagonists, Seminars in Cardiothoracic and Vascular Anesthesia, 10.1177/108925329800200305, 2:3, (222-230), Online publication date: 1-Sep-1998. Guimarães S, Paiva M and Moura D (2009) Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries, British Journal of Pharmacology, 10.1038/sj.bjp.0701959, 124:6, (1207-1212), Online publication date: 1-Jul-1998. Goutsouliak V and Rabkin S (1998) Comparison of Angiotensin II Type-1 and Type-2 Receptor Antagonists on Angiotensin II– Induced IP3 Generation in Cardiomyocytes, General Pharmacology: The Vascular System, 10.1016/S0306-3623(97)00270-X, 30:3, (367-372), Online publication date: 1-Mar-1998. Yee D, Heerding J, Krichavsky M and Fluharty S (1998) Role of the amino terminus in ligand binding for the angiotensin II type 2 receptor, Molecular Brain Research, 10.1016/S0169-328X(98)00104-1, 57:2, (325-329), Online publication date: 1-Jun-1998. Rabkin S (1998) Cardiac Angiotensin II Subtype 2 Receptor Signal Transduction Pathways: Embryonic Cardiomyocytes and Human Heart Angiotensin II Receptor Blockade Physiological and Clinical Implications, 10.1007/978-1-4615-5743-2_27, (367-384), . Asano K, Dutcher D, Port J, Minobe W, Tremmel K, Roden R, Bohlmeyer T, Bush E, Jenkin M, Abraham W, Raynolds M, Zisman L, Perryman M and Bristow M (1997) Selective Downregulation of the Angiotensin II AT1-Receptor Subtype in Failing Human Ventricular Myocardium, Circulation, 95:5, (1193-1200), Online publication date: 4-Mar-1997. Dowell F, Benessiano J, Poitevin P, Levy B and Henrion D (1997) Effects of chronic losartan treatment on vascular reactivity in normotensive rats, Journal of Hypertension, 10.1097/00004872-199715050-00008, 15:5, (523-529), Online publication date: 1-May-1997. Hirata T, Goto S, Tamura K, Okuhira M and Nagao Y (1997) Quantitative structure-activity relationships of benzoyliminothiadiazoline derivatives as angiotensin II receptor antagonists, Bioorganic & Medicinal Chemistry Letters, 10.1016/S0960-894X(97)00026-7, 7:4, (385-388), Online publication date: 1-Feb-1997. Tamaki T, Nishiyama A, Kimura S, Aki Y, Yoshizumi M, Houchi H, Morita K and Abe Y (1997) EXP3174: The Major Active Metabolite of Losartan, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1997.tb00327.x, 15:2, (122-136), Online publication date: 1-Jun-1997. Jin D, Song K, Oka Y, Takai S, Shiota N and Miyazaki M (1997) Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo, Japanese Journal of Pharmacology, 10.1254/jjp.75.259, 75:3, (259-266), . Bermann M, Walsh M and Sowers J (1997) Angiotensin-II Biochemistry and Physiology: Update on Angiotensin-II Receptor Blockers, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1997.tb00325.x, 15:1, (75-100), Online publication date: 1-Mar-1997. Mattiazzi A (1997) Positive inotropic effect of Angiotensin II. Increases in intracellular Ca2+ or changes in myofilament Ca2+ responsiveness?, Journal of Pharmacological and Toxicological Methods, 10.1016/S1056-8719(97)00020-8, 37:4, (205-214), Online publication date: 1-Jun-1997. Rosenkranz S, Nickenig G, Flesch M, Cremers
Referência(s)